Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE976
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM15272
GPL96
APL1 primary APL cells Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004.
GSM15394
GPL96
APL2 primary APL cells Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15395
GPL96
APL_RA1 primary APL cells treated with ATRA Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 1uM ATRA for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15412
GPL96
APL_RA2 primary APL cells treated with ATRA Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 1uM ATRA for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15413
GPL96
APL_Keto1 primary APL cells treated with 16-ketoestradiol Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 70uM 16-ketoestradiol for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15414
GPL96
APL_Keto2 primary APL cells treated with 16-ketoestradiol Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 70uM 16-ketoestradiol for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15415
GPL96
APL_Phen1 primary APL cells treated with 1,10-phenanthroline Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 1 uM 1,10-phenanthroline for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15416
GPL96
APL_Phen2 primary APL cells treated with 1,10-phenanthroline Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 1 uM 1,10-phenanthroline for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15417
GPL96
APL_EGFR1 prikmary APL cells treated with 4,5-dianilinophthalimide Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 25 uM 4,5-dianilinophthalimide for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15418
GPL96
APL_EGFR2 primary APL cells treated with 4,5-dianilinophthalimide Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 25 uM 4,5-dianilinophthalimide for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15419
GPL96
APL_Erythro1 primary APL cells treated with erythro-9-(2-hydroxy-3-nonyl) adenine HCl Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 70 uM erythro-9-(2-hydroxy-3-nonyl) adenine HCl for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15420
GPL96
APL_Erythro2 primary APL cells treated with erythro-9-(2-hydroxy-3-nonyl) adenine HCl Sample from a leukopharesis of a patient with acute promyelocytic leukemia (APL) with a t(15;17) and a white blood cell count of 185,000 with 97% myeloblasts at diagnosis treated with 70 uM erythro-9-(2-hydroxy-3-nonyl) adenine HCl for 5 days. Target preparation and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = APL Leukemia
GSM15421
GPL96
AML1 primary patient AML cells Adult AML sample obtained from the Cancer and Leukemia Group (CALGB) leukemia bank, collected and processed as previously reported in Golub et al., Science, 286 (1999), p531-537. Samples were selected without regard to immunophenotype, cytogenetics, or other molecular features. Hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = AML Leukemia
GSM15422
GPL96
AML2 primary patient AML cells Adult AML sample obtained from the Cancer and Leukemia Group (CALGB) leukemia bank, collected and processed as previously reported in Golub et al., Science, 286 (1999), p531-537. Samples were selected without regard to immunophenotype, cytogenetics, or other molecular features. Hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = AML Leukemia
GSM15423
GPL96
AML3 primary patient AML cells Adult AML sample obtained from the Cancer and Leukemia Group (CALGB) leukemia bank, collected and processed as previously reported in Golub et al., Science, 286 (1999), p531-537. Samples were selected without regard to immunophenotype, cytogenetics, or other molecular features. Hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = AML Leukemia
GSM15424
GPL96
AML4 primary patient AML cells Adult AML sample obtained from the Cancer and Leukemia Group (CALGB) leukemia bank, collected and processed as previously reported in Golub et al., Science, 286 (1999), p531-537. Samples were selected without regard to immunophenotype, cytogenetics, or other molecular features. Hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = AML Leukemia
GSM15425
GPL96
AML5 primary patient AML cells Adult AML sample obtained from the Cancer and Leukemia Group (CALGB) leukemia bank, collected and processed as previously reported in Golub et al., Science, 286 (1999), p531-537. Samples were selected without regard to immunophenotype, cytogenetics, or other molecular features. Hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = AML Leukemia
GSM15426
GPL96
AML6 primary patient AML cells Adult AML sample obtained from the Cancer and Leukemia Group (CALGB) leukemia bank, collected and processed as previously reported in Golub et al., Science, 286 (1999), p531-537. Samples were selected without regard to immunophenotype, cytogenetics, or other molecular features. Hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = AML Leukemia
GSM15427
GPL96
poly1 normal human neutrophils Normal peripheral blood neutrophils isolated using Ficoll-Paque separation from a donor leukopack discard sample provided by the Dana Farber Cancer Institute Blood Bank. RNA extraction, target preparation, and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = neutrophil
GSM15428
GPL96
poly2 normal human neutrophils Normal peripheral blood neutrophils isolated using Ficoll-Paque separation from a donor leukopack discard sample provided by the Dana Farber Cancer Institute Blood Bank. RNA extraction, target preparation, and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = neutrophil
GSM15429
GPL96
poly3 normal human neutrophils Normal peripheral blood neutrophils isolated using Ficoll-Paque separation from a donor leukopack discard sample provided by the Dana Farber Cancer Institute Blood Bank. RNA extraction, target preparation, and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = neutrophil
GSM15430
GPL96
mono1 normal human monocytes Normal peripheral blood monocytes isolated using Ficoll-Paque separation from a donor leukopack discard sample provided by the Dana Farber Cancer Institute Blood Bank. RNA extraction, target preparation, and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = monocyte
GSM15431
GPL96
mono2 nomral human monocytes Normal peripheral blood monocytes isolated using Ficoll-Paque separation from a donor leukopack discard sample provided by the Dana Farber Cancer Institute Blood Bank. RNA extraction, target preparation, and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = monocyte
GSM15432
GPL96
mono3 normal human monocytes Normal peripheral blood monocytes isolated using Ficoll-Paque separation from a donor leukopack discard sample provided by the Dana Farber Cancer Institute Blood Bank. RNA extraction, target preparation, and hybridization as described in Stegmaier et al., Nature Genetics 2004. Keywords = monocyte
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes